{
  "ptid_time": "009_S_4324_2011-11-01",
  "img_path": "/data/qiuhui/data/adni/images/009_S_4324/2011-11-01/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 50,109 mm³, 124.3% above the reference mean. With a Z-score of 3.11 (99.9th percentile), this represents profound enlargement; hippocampal volume measures 6,059 mm³, 21.2% below the reference mean. With a Z-score of -2.37 (0.9th percentile), this represents significant atrophy; whole brain volume measures 878,160 mm³, 14.7% below the reference mean. With a Z-score of -1.83 (3.4th percentile), this represents moderate atrophy; entorhinal cortex volume measures 2,609 mm³, 33.0% below the reference mean. With a Z-score of -2.56 (0.5th percentile), this represents significant atrophy; fusiform gyrus volume measures 14,367 mm³, 21.1% below the reference mean. With a Z-score of -2.38 (0.9th percentile), this represents significant atrophy; middle temporal gyrus volume measures 17,098 mm³, 16.7% below the reference mean. With a Z-score of -1.48 (6.9th percentile), this represents mild atrophy. ",
  "text_data": "Age is 62.8 years. Gender is Female. Education: 14 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Smoking. MMSE: 27.0. MoCA: 21.0. Logical Memory: 1.0. Laboratory findings: Monocytes: 0.64 (significant elevated); WBC: 9.20 (significant elevated); Lymphocytes: 2.79 (significant elevated); Calcium (EDTA): 11.60 (profound elevated); Triglycerides (GPO): 267.00 (significant elevated); GGT: 103.00 (profound elevated); ALT (SGPT): 34.00 (significant elevated). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.48 SUVR (profound elevated); Amyloid beta: 342.60 pg/mL (moderate reduced); Total tau: 140.70 pg/mL (mild reduced); Phosphorylated tau: 15.05 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows profound ventricular enlargement and significant atrophy in the hippocampus, entorhinal cortex, and fusiform gyrus—key regions affected in Alzheimer’s disease (AD). The MoCA score of 21 suggests mild cognitive impairment (MCI), while the elevated AV45 (amyloid PET) and APOE4 positivity strongly support underlying AD pathology.  \n\n**Diagnosis:** **MCI (likely due to Alzheimer’s disease)**  \n**Confidence:** **High**  \n\n*(Note: While the MMSE is borderline normal (27), the MoCA and biomarker/imaging findings align with MCI-AD. The absence of severe functional decline rules out dementia at this stage.)*",
  "timestamp": "2025-07-25T22:17:57.879347"
}